Teresa Scassa - Blog

Tags

access to information AI AIDA AI governance AI regulation Ambush Marketing artificial intelligence big data bill c11 Bill c27 copyright data governance data protection Electronic Commerce freedom of expression Geospatial geospatial data intellectual property Internet internet law IP open courts open data open government personal information pipeda Privacy smart cities trademarks transparency
Monday, 26 March 2001 09:55

Patents for Second Medical Indications: Issues and Implications for Pharmacare in Canada

Written by  Teresa Scassa
Rate this item
(0 votes)

"Patents for Second Medical Indications:  Issues and Implications for Pharmacare in Canada" (March 26, 2001).  Report prepared for Health Canada.

Last modified on Thursday, 18 August 2011 11:41
Read 83039 times
Published in Reports/Consultations
Tagged under
Social sharing
Teresa Scassa

Teresa Scassa

Latest from Teresa Scassa

Related items (by tag)

More in this category: « An Analysis of Legal and Technological Privacy Implications of Radio Frequency Identification Technologies
Login to post comments
back to top

Canadian Trademark Law

Published in 2015 by Lexis Nexis

Canadian Trademark Law 2d Edition

Buy on LexisNexis

Electronic Commerce and Internet Law in Canada, 2nd Edition

Published in 2012 by CCH Canadian Ltd.

Electronic Commerce and Internet Law in Canada

Buy on CCH Canadian

Intellectual Property for the 21st Century

Intellectual Property Law for the 21st Century:

Interdisciplinary Approaches

Purchase from Irwin Law
Joomla Templates by Joomlashack